Guangdong Tong
- Hepatology top 10%
- Hepatitis C virus research 8
- Liver Disease and Transplantation 5
- Pharmacology top 5%
- Phytochemistry and Bioactivity Studies 7
- Pharmacological Effects of Natural Compounds 7
-
- Traditional Chinese Medicine Analysis 3
-
- Liver Disease Diagnosis and Treatment 20
- Hepatitis B Virus Studies 13
-
- Lipid metabolism and disorders 4
In The Last Decade
Guangdong Tong
44 papers receiving 459 citations
Peers
Comparison fields: 5 of 68
- Hepatology 85
- Pharmacology 85
- Complementary and alternative medicine 55
- Cancer Research 75
- Epidemiology 164
Countries citing papers authored by Guangdong Tong
This map shows the geographic impact of Guangdong Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangdong Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangdong Tong more than expected).
Fields of papers citing papers by Guangdong Tong
This network shows the impact of papers produced by Guangdong Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangdong Tong. The network helps show where Guangdong Tong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guangdong Tong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 11 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 57 | |
| 8 | 2023 | 20 | |
| 9 | 2022 | 15 | |
| 10 | 2022 | 9 | |
| 11 | 2022 | 6 | |
| 12 | 2021 | 15 | |
| 13 | 2020 | 32 | |
| 14 | 2019 | 13 | |
| 15 | 2016 | 5 | |
| 16 | 2013 | 5 | |
| 17 | Effects of Penthorum chinense Pursh extractum on TGF-β1 activated signal transduction within hepatic stellate cells | 2009 | 1 |
| 18 | Inhibition of extract of phyllanthus urinaria L.on hepatitis B virus and hepatitis B X gene in vitro | 2006 | 2 |
| 19 | 2006 | 7 | |
| 20 | 2006 | 1 |
About Guangdong Tong
Guangdong Tong is a scholar working on Hepatology, Pharmacology and Epidemiology, having authored 48 papers that have together received 463 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (20 papers), Hepatitis B Virus Studies (13 papers), Hepatitis C virus research (8 papers), Phytochemistry and Bioactivity Studies (7 papers), Pharmacological Effects of Natural Compounds (7 papers), Liver Disease and Transplantation (5 papers), Lipid metabolism and disorders (4 papers) and Traditional Chinese Medicine Analysis (3 papers). The work is most often cited by research in Hepatology (85 citations), Pharmacology (85 citations) and Complementary and alternative medicine (55 citations). Guangdong Tong has collaborated with scholars based in China, Macao and Denmark. Frequent co-authors include Yufeng Xing, Chunshan Wei, Mingtai Chen, Hua Zhou, Xiaoyan Jiang, Furong Huang, Xiang Cui, Mengnan Liu, Zhiyi Han and Hao He. Their work appears in journals such as PLoS ONE, Journal of Hepatology and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.